Biosimilars reimbursement issues, no specific bill H.R. 3, Prescription drug pricing issues FDA issues, no specific bill Supply Chain Issues, no specific bill Patent thickets/product hopping, no specific bill Mergers/acquisitions, no specific bill H.R. 19 Lower Costs, More Cures Act of 2021 H.R. 5260 Reduced Costs and Continued Cures Act H.R.5376, "Build Back Better Act Issues related to clinical trial diversity S. 99 The Medicare Drug Price Negotiation Act, issues related to international reference pricing and Part D redesign H.R. 3 Elijah E. Cummings Lower Drug Costs Now Act, issues related to international reference pricing and Part D redesign S. 1943 and H.R. 3517, Issues related to DXA, osteoporosis Issues related to international reference pricing Issues related to the 340B program, no specific bill Reimbursement for biologics/biosimilars Issues related to Medicare Part D redesign Issues related to patient affordability issues, including copay cards, copay accumulators, National Benefit Payment Parameters ESRD bundle, calcimimetic access, no specific bill H.R. 19 Lower Costs, More Cures Act of 2021, issues related to international reference pricing and Part D redesign H.R. 5260 Reduced Costs and Continued Cures Act, issues related to international reference pricing and Part D redesign S. 2428 False Claims Amendments Act of 2021 H.R. 5376 Build Back Better Act, issues related to international reference pricing and Part D redesign H.R. 5801 HELP Copays Act Issues related to corporate and international tax, including regarding Public Law 115-97, Tax Cuts and Jobs Act Issues related to Puerto Rico H.R. 7527, Medical Manufacturing, Economic Development, and Sustainability Act of 2020 H.R. 6930, Manufacturing API, Drugs, and Excipients (MADE) in America Act of 2020 Proposed Rule, Guidance Related to the Foreign Tax Credit, Clarification of Foreign-Derived Intangible Income Issues related to OECD negotiations on the taxation of global income H.R.5376, "Build Back Better Act S. 4783, Territory Economic Development Tax Credit Act S.1435 Affordable Prescriptions for Patients Act H.R.2873 Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act S. 2428 False Claims Amendments Act of 2021 Mergers and acquisitions, no specific bill
HCR - Health Issues MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AMGEN, INC.
601 13th Street, NW, 11th Floor North, WASHINGTON, DC, 20005, US
KIMBERLY LOVE (Senator Debbie Stabeow (D-MI), left 2011, Legislative Director) WILLIAM O'BRIEN HELEN RHEE JESSE KERNS L NICOLE CURRIE GREGORY PORTNER VICTORIA BLATTER HOWARD MOON RUTH HOFFMAN JORDAN LYNN LAYSON KIMBERLY LOVE (Senator Debbie Stabeow (D-MI), left 2011, Legislative Director) L NICOLE CURRIE GREGORY PORTNER HELEN RHEE JESSE KERNS VICTORIA BLATTER WILLIAM O'BRIEN HOWARD MOON RUTH HOFFMAN JORDAN LYNN LAYSON L NICOLE CURRIE HELEN RHEE JORDAN LYNN LAYSON KIMBERLY LOVE (Senator Debbie Stabeow (D-MI), left 2011, Legislative Director) HELEN RHEE GREGORY PORTNER L NICOLE CURRIE WILLIAM O'BRIEN VICTORIA BLATTER HOWARD MOON JESSE KERNS JORDAN LYNN LAYSON
Senator Debbie Stabeow (D-MI), left 2011, Legislative Director Senator Debbie Stabeow (D-MI), left 2011, Legislative Director Senator Debbie Stabeow (D-MI), left 2011, Legislative Director